Clarithromycin as Immunomodulator for the Management of Sepsis

Clinical trial NCT01223690 · COMPLETED

Trial details

NCT number: NCT01223690
Sponsor: University of Athens
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sepsis Severe Sepsis Septic Shock

Start date: 2007-07-01
Primary completion: 2010-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.